Indiana University Health’s unique partnership with Indiana University School of Medicine, one of the nation’s leading medical schools, gives patients access to innovative treatments and therapies.
Indiana University Health and IU School of Medicine work in partnership to train physicians, blending breakthrough research and treatments with the highest quality of patient care. Each year more than 1,000 residents and fellows receive training in IU Health hospitals. Research conducted by IU School of Medicine faculty gives IU Health physicians and patients access to the most cutting edge and comprehensive treatment options.
In 2012, IU Health and the IU School of Medicine announced that they will invest $150 million over five years in the Strategic Research Initiative, a new research collaboration that will enhance the institutions’ joint capabilities in fundamental scientific investigation, translational research and clinical trials. The initial focus will be on projects in the fields of neuroscience, cancer and cardiovascular disease with the goal to fund transformative proposals that will fundamentally change our understanding of these diseases and lead to important new therapies for patients.
The three target research areas represent research strengths at IU School of Medicine, key strategic service lines for IU Health, and important medical needs in a time of an aging population and rising healthcare costs:
- Cancer: One of the initiative’s primary goals is to enable the IU Health Melvin and Bren Simon Cancer Center to attain the National Cancer Institute’s top status of “comprehensive,” which would recognize it as one of the top-tier cancer centers in the nation.
- Neuroscience: The neurosciences research program will tackle a broad range of brain injuries, neurodegenerative disorders and neurodevelopmental disorders.
- Cardiovascular: The cardiovascular research initiative will develop a comprehensive program for the study and treatment of heart failure, from newborns to older adults. A top priority is developing a cardiovascular genetics program.
The Strategic Research Initiative will provide patients with access to internationally renowned physicians and to new therapies developed through translational research and clinical trials, and will make use of the latest genetic tools to develop personalized therapies that are more effective for individuals and efficient for healthcare providers.